Since 24 July 2026, Tunisian pharmacies have been applying a new price list for nearly 300 medications. The move came as a surprise, announced without prior consultation with professionals, leaving many wondering how to navigate the changes. We break down the stakes and the steps you should take to stay informed.
Why did this price review catch pharmacists off guard?
The Central Pharmacy of Tunisia (PCT) released a revised price list for nearly 300 medications on Friday, 24 July 2026. Yet, according to the Tunisian Union of Private Pharmacy Owners, the decision blindsided professionals. In a statement, the union highlighted that community pharmacists were not consulted beforehand, leaving key details of the rollout unclear.
This lack of prior communication has raised concerns, as the union’s national office points out. Without dialogue or clear guidelines, pharmacists are now grappling with a measure already in effect, its full implications still hazy.
Which medications are affected by the price adjustments?
The Central Pharmacy of Tunisia (PCT) issued a new price list yesterday covering nearly 300 prescription drugs. The changes, formalised in a circular, apply to medications available across the country, with no therapeutic class specified at this stage.
This public price revision targets a precise list of 300 products, with labels required to reflect the updated costs immediately. While the PCT has yet to release the full list of affected items, the move aims to standardise prices while ensuring continued access to essential treatments.
How are Tunisian pharmacists handling the price transition?
As soon as the price changes were announced, the Tunisian Union of Private Pharmacy Owners moved to clarify its stance. In an official statement, it confirmed that the 300 affected medications would be immediately restocked at the new prices, despite initial uncertainties. The priority: avoiding shortages and maintaining uninterrupted care.
On the ground, pharmacists are implementing the PCT’s circular without delay. Some have opted to display both old and new prices side by side until existing stock is sold. A small measure of transparency, they hope, to reassure customers already strained by economic instability.
With these adjustments in place, staying alert is key. Take a moment to check the labels and don’t hesitate to ask your pharmacist for advice—they’re your best guide through these changes. After all, clear information is the first step to easing concerns.
